Trajectories of drug use among French young people: Prototypical stages of involvement in illicit drug use
Stéphanie Baggio, Stanislas Spilka, Joseph Studer, Katia Iglesias, Gerhard Gmel
Journal of Substance Use January 20, 2016 DOI: 10.3109/14659891.2015.1063720 via OpenAlex
Summary
AI-generated from the abstractAmong French 17-year-olds, patterns of illicit drug use fall into two distinct groups: one including amphetamines, cocaine, ecstasy, magic mushrooms, poppers, and solvents; the other including crack, GHB, heroin, LSD, and ketamine. Trajectories typically involve the first group before the second. Preventive efforts should target early teens, as very young users are more likely to progress to illicit drug use. The findings suggest that future studies should distinguish these two groups rather than lumping all illicit drugs together.
Study at a glance
| Characteristics | Cross-sectional survey with latent class and survival analyses Peer reviewed |
|---|---|
| Sample size | 23,882 |
| Population | French 17-year-olds from the 2011 ESCAPAD survey |
| Topics | Cannabis MDMA |
| Keywords | Illicit drug Medicine |
| Citations | 9 |
| Key finding | Patterns of illicit drug use among French 17-year-olds separate into two distinct groups, with use of the first group (amphetamines, cocaine, ecstasy, magic mushrooms, poppers, solvents) typically preceding use of the second group (crack, GHB, heroin, LSD, ketamine). |
Abstract
Aims: This study investigated patterns and trajectories of substance use, with a special focus on illicit drugs other than cannabis. It examined both patterns and trajectories of use among a general population-based sample. Methods: We used data from the 2011 French ESCAPAD survey of French 17-year-olds to assess exposure and age of initiation of 14 licit and illicit drugs (N=23,882). Latent class analysis (LCA) and survival analyses were performed. Results: The results of the LCA showed that patterns of illicit drug use clearly distinguished between two groups of other illicit drugs: 1) amphetamines/speed, cocaine, ecstasy/MDMA, magic mushrooms, poppers, and solvents; 2) crack/freebase, GHB/GBL, heroine, LSD, and ketamine. Survival analyses highlighted that trajectories involved the first group before the second one. Conclusions: Prototypical drug use patterns and trajectories should include a distinction between two groups of illicit drugs. Preventive actions should focus on young people in their early teens, since very young users are more likely to progress to illicit drug use, and further studies should include this distinction instead of aggregating other illicit drugs into a single category.